levonorgestrel has been researched along with Obesity in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.00) | 29.6817 |
| 2010's | 38 (76.00) | 24.3611 |
| 2020's | 10 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, DF; Bond, K; Cherala, G; Edelman, AB; Hennebold, JD; Jensen, JT; Lim, JY | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Agarwal, R; González, JL; Hong, KM; Klar, M; Mandelbaum, RS; Matsuo, K; Obermair, A; Paulson, RJ; Roman, LD; Violette, CJ; Wright, JD | 1 |
| Barr, CE; Crosbie, EJ | 2 |
| Farthing, A | 1 |
| Gkegkes, I; Iavazzo, C; Vrachnis, N | 1 |
| Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
| Bernard, L; Ferguson, SE; Kwon, JS; Pina, A; Reade, CJ; Simpson, AN; Sinasac, S | 1 |
| Aiken, ARA; Chiodo, JA; Edelman, A; Garner, EIO; Portman, DJ; Trussell, J | 1 |
| Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
| Kardos, L; Luczai, E; Magyar, G; Schváb, E | 1 |
| Edelman, AB; Jusko, WJ; Luo, D; Natavio, M; Stanczyk, FZ; Westhoff, CL | 1 |
| Jusko, WJ; Molins, EAG; Natavio, M; Nelson, A; Stanczyk, FZ | 1 |
| Bullard, KA; Edelman, AB; Rodriguez, MI; Williams, SM | 1 |
| Cleland, K; Smith, NK; Trussell, J; Wagner, B | 1 |
| Bender, NM; Mishell, DR; Montoro, M; Najera, SO; Segall-Gutierrez, P; Stanczyk, FZ | 1 |
| Schorge, JO | 1 |
| Mayeda, ER; Torgal, AH; Westhoff, CL | 1 |
| Eggertson, L | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Armes, J; Brennan, D; Gebski, V; Hawkes, AL; Janda, M; Obermair, A; Quinn, M | 1 |
| Cherala, G; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Kohn, JE; Lopez, PM; Simons, HR | 1 |
| Reiter, L; Westergren, T | 1 |
| Harris, SC; Kaneshiro, BE; Saito-Tom, LY; Salcedo, J; Soon, RA | 1 |
| Blue, SW; Cherala, G; Edelman, AB; Erikson, DW; Jensen, JT | 1 |
| Jusko, WJ | 1 |
| Chino, J; Dottino, JA; Hasselblad, V; Havrilesky, LJ; Myers, ER; Secord, AA | 1 |
| Blumenthal, PD; Fok, WK | 1 |
| Coomarasamy, C; Ekeroma, AJ; Shaw, V; Vandal, AC | 1 |
| Cameron, JL; Carlson, NE; Cherala, G; Edelman, AB; Jensen, JT; Munar, MY; Stanczyk, FZ; Stouffer, RL | 1 |
| Edelman, A; Patel, S; Stanczyk, FZ; Steiner, AZ | 1 |
| Burke, AE; McDonald-Mosley, R | 1 |
| Weisberg, E | 1 |
| Mayeda, ER; Pike, MC; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
| Benn, EKT; Lerner, JP; Mayeda, ER; Paik, M; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
| Cansino, C; Curtis, KM; Jamieson, DJ; Paulen, ME; Zapata, LB | 1 |
| Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT | 1 |
| Hillman, JB; Inge, TH; Miller, RJ | 1 |
| Beasley, A; Estes, C; Guerrero, J; Westhoff, C | 1 |
| Mayeda, ER; Pike, MC; Shimoni, N; Stanczyk, FZ; Torgal, AT; Westhoff, CL | 1 |
| Cherala, G; Edelman, A; Elman, MR; Koop, D; Munar, M | 1 |
| Concin, H; Concin, N; Griesmacher, A; Gschliesser, A; Gschlieβer, A; Mattle, V; Moser, C; Seeber, B; Seger, C; Wildt, L; Ziehr, SC | 1 |
| Archer, DF; Foegh, M; Mishell, DR; Rubin, A; Stanczyk, FZ | 1 |
| Batur, P | 1 |
| D'Alessandro, P; Di Cello, A; Mocciaro, R; Morelli, M; Venturella, R; Zullo, F | 1 |
| Cherala, G; Dubois, B; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
| Kübler, W; Nawroth, PP; Salbach, B; Salbach, PB; von Holst, Th | 1 |
6 review(s) available for levonorgestrel and Obesity
| Article | Year |
|---|---|
Levonorgestrel emergency contraception and bodyweight.
Topics: Body Weight; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Pregnancy Rate | 2019 |
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
Topics: Clinical Studies as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Humans; Levonorgestrel; Obesity | 2019 |
Clarification of contraceptive drug pharmacokinetics in obesity.
Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity | 2017 |
Update on emergency contraception.
Topics: Adult; Contraception; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norpregnadienes; Obesity; Pregnancy | 2016 |
Contraceptive use among women with a history of bariatric surgery: a systematic review.
Topics: Bariatric Surgery; Contraceptives, Oral; Female; Gastric Bypass; Gastroplasty; Humans; Levonorgestrel; Obesity; Pregnancy; PubMed; Weight Loss | 2010 |
Emergency contraception: separating fact from fiction.
Topics: Abortion, Induced; Contraception, Postcoital; Counseling; Crime Victims; Female; Hospitals; Humans; Intrauterine Devices, Copper; Levonorgestrel; Mifepristone; Nonprescription Drugs; Norpregnadienes; Obesity; Practice Patterns, Physicians'; Pregnancy; Pregnancy, Unplanned; Sex Offenses; United States | 2012 |
14 trial(s) available for levonorgestrel and Obesity
| Article | Year |
|---|---|
Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial.
Topics: Adult; Contraception, Postcoital; Female; Humans; Levonorgestrel; Obesity; Ovulation; Progesterone | 2022 |
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.
Topics: Adenocarcinoma; Biomarkers, Tumor; Diet; Endometrial Neoplasms; Exercise; Female; Humans; Intrauterine Devices; Levonorgestrel; Metformin; Neoplasm Staging; Obesity; Prospective Studies; Research Design; Weight Loss | 2014 |
Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Prospective Studies; Young Adult | 2014 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Menstrual Cycle; Obesity; Organ Size; Ovarian Follicle; Ovulation Inhibition; Progesterone; Radioimmunoassay; Ultrasonography; Young Adult | 2010 |
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Ovary; Prospective Studies; Young Adult | 2010 |
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult | 2012 |
Predictors of noncompliance in an oral contraceptive clinical trial.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Educational Status; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Levonorgestrel; Medication Adherence; Obesity; Ovarian Follicle; Ovulation Inhibition; Patient Dropouts; Poverty; Single-Blind Method; United States; Young Adult | 2012 |
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.
Topics: Adolescent; Adult; Chromatography, Liquid; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Midazolam; Obesity; Prospective Studies; Tandem Mass Spectrometry; Young Adult | 2012 |
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Middle Aged; Obesity; Ovary; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 2013 |
Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Body Mass Index; Body Weight; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Leptin; Levonorgestrel; Middle Aged; Obesity; Postmenopause | 2000 |
30 other study(ies) available for levonorgestrel and Obesity
| Article | Year |
|---|---|
The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
Topics: Adult; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Female; Fertility Preservation; Glucagon-Like Peptide-1 Receptor; Humans; Levonorgestrel; Obesity; Polycystic Ovary Syndrome; Pregnancy; Progestins | 2023 |
The Mirena coil is a suitable treatment of early-stage endometrial cancer in obese women: FOR: Careful selection and monitoring is key.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Contraindications, Procedure; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Monitoring, Physiologic; Obesity; Patient Selection; Progesterone Congeners | 2020 |
The Mirena coil is a suitable treatment of early-stage endometrial cancer in obese women: AGAINST: Please follow the manufacturer's advice.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Contraindications, Drug; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Staging; Obesity; Pamphlets; Patient Education as Topic; Progesterone Congeners | 2020 |
Authors' reply re: Mirena Coil is a suitable treatment of early-stage endometrial cancer in obese women: FOR or AGAINST?: Treat the patient, not the disease.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obesity | 2020 |
Re: Mirena Coil is a suitable treatment of early stage endometrial cancer in obese women: FOR or AGAINST?
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obesity | 2020 |
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
The levonorgestrel intrauterine system for prevention of endometrial cancer in women with obesity: A cost-effectiveness study.
Topics: Age Factors; Aged; Aged, 80 and over; Canada; Contraceptive Agents, Hormonal; Cost-Benefit Analysis; Endometrial Neoplasms; Female; Health Care Costs; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Markov Chains; Middle Aged; Models, Economic; Obesity; Retrospective Studies; Risk Factors | 2021 |
The emerging role of obesity in short-acting hormonal contraceptive effectiveness.
Topics: Administration, Cutaneous; Body Mass Index; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Effectiveness; Female; Humans; Levonorgestrel; Obesity | 2018 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index.
Topics: Administration, Oral; Adolescent; Adult; Body Mass Index; California; Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Obesity; Obesity, Morbid; Prospective Studies; Radioimmunoassay; Young Adult | 2019 |
Ulipristal acetate compared to levonorgestrel emergency contraception among current oral contraceptive users: a cost-effectiveness analysis.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Cost-Benefit Analysis; Female; Humans; Levonorgestrel; Models, Theoretical; Norpregnadienes; Obesity; Pregnancy; Pregnancy, Unplanned; United States; Young Adult | 2019 |
"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online.
Topics: Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Labeling; Female; Humans; Levonorgestrel; Norpregnadienes; Obesity; Pharmaceutical Services, Online; United States | 2020 |
Effects of progestin-only long-acting contraception on metabolic markers in obese women.
Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Desogestrel; Fasting; Female; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intrauterine Devices, Medicated; Levonorgestrel; Metabolic Syndrome; Obesity; Progestins; Prospective Studies; Waist Circumference | 2013 |
Nonsurgical treatment of endometrial hyperplasia: is the road less traveled the one we should be taking more?
Topics: Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Minimally Invasive Surgical Procedures; Obesity; Progestins | 2013 |
Plan B emergency contraceptive may be ineffective for heavier women.
Topics: Canada; Contraceptives, Postcoital; Drug Labeling; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Treatment Failure | 2014 |
Weight and body mass index among female contraceptive clients.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Cross-Sectional Studies; Female; Humans; Levonorgestrel; Obesity; Prevalence; United States; Young Adult | 2015 |
[Emergency prevention in overweight--to be trusted?].
Topics: Body Mass Index; Contraceptives, Postcoital, Synthetic; Female; Humans; Levonorgestrel; Obesity; Pregnancy | 2015 |
Levonorgestrel Intrauterine Device Use in Overweight and Obese Women.
Topics: Adult; Contraception; Contraceptive Agents, Female; Female; Hawaii; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Male; Obesity; Overweight; Retrospective Studies; Young Adult | 2015 |
Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Contraception, Postcoital; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Menstrual Cycle; Obesity; Oregon; Prospective Studies; Young Adult | 2016 |
Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.
Topics: Body Mass Index; Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Models, Economic; Monte Carlo Method; Obesity | 2016 |
The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Obesity; Prospective Studies; Quality of Life; Surveys and Questionnaires; Visual Analog Scale | 2016 |
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Luteinizing Hormone; Obesity; Young Adult | 2009 |
Antimullerian hormone and obesity: insights in oral contraceptive users.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Levonorgestrel; Luteinizing Hormone; Obesity; Regression Analysis | 2010 |
Contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Monitoring; Female; Humans; Levonorgestrel; Menorrhagia; Obesity; Pelvic Pain | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity | 2011 |
Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.
Topics: Adolescent; Bariatric Surgery; Cohort Studies; Contraception; Contraceptive Agents, Female; Databases, Factual; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Obesity; Ohio; Patient Acceptance of Health Care; Young Adult | 2011 |
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Austria; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Obesity; Overweight; Practice Guidelines as Topic; Retrospective Studies; Time Factors; Young Adult | 2012 |
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Topics: Administration, Intravaginal; Aged; Body Mass Index; Cell Proliferation; Drug Delivery Systems; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Obesity; Overweight; Postmenopause; Retrospective Studies; Risk; Secondary Prevention; Uterine Hemorrhage | 2013 |
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Progesterone; Prospective Studies | 2013 |